Navigation Links
China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results
Date:7/10/2008

4,574

Capital and statutory reserves 3,025,794 3,025,794

Total stockholders' equity 44,395,267 23,910,007

Total liabilities and stockholders'

equity $ 93,791,526 $ 44,579,844

CHINA-BIOTICS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOW

(Audited, amounts expressed in US Dollars)

FOR THE YEARS ENDED MARCH 31, 2008 AND 2007

CASH FLOWS FROM OPERATING ACTIVITIES 2008 2007

Net income 17,542,244 $10,904,986

Adjustment for:

Gain on disposal of plant and

equipment -- (14,793)

Depreciation 999,148 493,472

Change in fair value of convertible

notes (3,366,000) --

(Increase)/Decrease in restricted

cash -- 748,742

(Increase)/Decrease in accounts

receivable 2,261,918 (2,881,034)

(Increase)/Decrease in inventories (154,189) 65,303

(Increase)/Decrease in prepayment (1,418,658) (352,923)

(Increase)/Decrease in other

receivables 2,732

Increase/(Decrease) in accounts

payable 1,036,521 (451,305)

Increase in income tax and surcharge

tax payable 5,008,143 4,186,868

Income tax paid (2,969,765) (2,373,846)

Increase/(Decrease) in other payables

and accruals, and value added tax

payable
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. China-Biotics, Inc. to Present at Chinas 3rd Annual Food Safety Technology Forum 2008
2. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results
3. China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company
4. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
5. China-Biotics, Inc. Completes Foundation for Its New Plant
6. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
7. China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results
8. China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site
9. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results
10. China-Biotics, Inc. Receives Approval to Begin Construction on Large-Scale Manufacturing Facility
11. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015  Ceres, Inc. (Nasdaq: ... a U.S. patent for a genetic sequence derived from ... as research, product development and plant transformation. The company ... biosynthetic processes that are the target of a class ... companies a commercial license to the innovation, including an ...
(Date:5/27/2015)... Madison, NJ (PRWEB) May 27, 2015 ... for evaluating the impact of regulation on medical innovation, ... Centered Innovation (iPCI) of Fairleigh Dickinson University’s ( ... inaugural MI3 Alert pertains to new FDA ... Senate proposal for accelerating the approval of certain medical ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Regenestem ... new stem cells clinic in Buenos Aires, Argentina. The ... renowned critical care specialist. Pastrana has assembled a multidisciplinary ... and orthopedics in her state-of-the-art Puerto Madero office. ... phase I to phase IV clinical studies in cellular ...
(Date:5/26/2015)... HILDEN, Deutschland, May 26, 2015 ... ®   ermöglicht klinischen Laboren ... dazugehöriger Berichte; Vorstellung auf den Konferenzen ClinGen, ... N.V. (NASDAQ: QGEN ; Frankfurt Prime ... QIAGEN Clinical Insight ® (QCI™) bekannt. ...
Breaking Biology Technology:Ceres Awarded Patent for Innovation in Soybean 2Ceres Awarded Patent for Innovation in Soybean 3Medical Innovation Impact Index Launched at Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) under the Rothman Institute 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 3QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 2QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 3QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 4QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 5QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 6
... - Brady Corp. , a manufacturer and ... extended its international reach by completing the acquisition of ... 2006. , ,Daewon, based in Seoul, South Korea, had ... 250 people in South Korea and China. The company ...
... conclude Wisconsin's economy is headed straight for a rusty dumpster. ... ,"About 260 at Briggs & Stratton to retire to secure ... site for plant." , ,But if you read these news ... is humming down the path to prosperity. , ,"Nursing home ...
... producer of brain imaging devices was looking for an ... it did not have to look far. , ,Three-year-old ... magnetic resonance imaging (fMRI) products and services, has entered ... Co. to promote its main product line, ...
Cached Biology Technology:Is Wisconsin's economy stronger, weaker, or just changing? 2Is Wisconsin's economy stronger, weaker, or just changing? 3
(Date:5/11/2015)... , May 11, 2015  Through a well-rounded UAS delegation ... had a strong showing at AUVSI,s Unmanned 2015 conference ... of Ohio,s UAS industry met with ... from all points along the UAS ecosystem. ... (DDC) Vice President for Aerospace Rich Knoll . "If ...
(Date:5/6/2015)... Israel , May 6, 2015 LifeBEAM, ... most established helmet producer, announced today that they will ... Helmet, the world,s first bio-sensing cycling helmet and the ... released in two new colors in order to give ... the product. In addition, LifeBEAM and Lazer announced their ...
(Date:4/21/2015)... Canada , April 21, 2015 ... and evolving government policies are boosting access control systems ... According to a recently published report by ... Opportunities, 2020 ", the access control systems market in ... nearly USD1.2 billion by 2020.The access control systems market ...
Breaking Biology News(10 mins):Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3
... common in the genetic disorder neurofibromatosis 1 (NF1),successfully ... tumor development, diagnosis and treatment, according to,researchers at ... validating their animal model, the team made two ... may be essential,to the initial formation of tumors ...
... (MBL) has published the results of an ... that, when combined, the pollutants,bromoform, chloroform, and ... to alter a key regulator in nerve,cell ... effects,of these pollutants individually, this is the ...
... The crystallized form of a molecular machine that can ... paths for treating diseases such as some forms of ... Purdue University researchers froze one of these molecular machines, ... intron, at mid-point in its work cycle. When frozen, ...
Cached Biology News:Mouse brain tumors mimic those in human genetic disorder 2Mouse brain tumors mimic those in human genetic disorder 3Clam embryo study shows pollutant mixture adversely affects nerve cell development 2Clam embryo study shows pollutant mixture adversely affects nerve cell development 3Molecular machine may lead to new drugs to combat human diseases 2Molecular machine may lead to new drugs to combat human diseases 3
Chaps Cell Extract Buffer can be used to lyse cells under nondenaturing conditions and is recommendedfor the preparation of cell lysates to be used with our caspase signaling pathway antibodies...
Rabbit polyclonal to Reptin/TIP49B/RUVB2 ( Abpromise for all tested applications). Antigen: Synthetic peptide (Human) Entrez Gene ID: 10856 Swiss Protein ID: Q6FIB9...
Anti-human L-Ficolin, Clone GN4, Monoclonal Antibody...
CD45/CD34 combination 50 tests...
Biology Products: